Medication-overuse headache in patients with cluster headache

Current Pain and Headache Reports

Volumn 12, Issue 2, 2008, Pages 122-127

  Paemeleire, Koen ^a   Evers, Stefan ^b   Goadsby, Peter J ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE PLUS CODEINE PLUS PARACETAMOL; ERGOTAMINE; ERGOTAMINE TARTRATE; INDOMETACIN; LITHIUM; METHYSERGIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYGEN; PARACETAMOL; PLACEBO; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL; ZOLMITRIPTAN;

ADULT; AGED; CASE MANAGEMENT; CASE REPORT; CLINICAL FEATURE; CLUSTER HEADACHE; DIAGNOSTIC ERROR; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG DOSE ESCALATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; HUMAN; MALE; MIGRAINE; PHENOTYPE; PRIMARY HEADACHE; REVIEW; UNSPECIFIED SIDE EFFECT;

AGED; ANALGESICS, OPIOID; CLUSTER HEADACHE; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS;

EID: 42049093589     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-008-0023-4     Document Type: Review

References (48)

1. Capobianco DJ, Swanson JW, Dodick DW: Medication-induced (analgesic rebound) headache: historical aspects and initial descriptions of the North American experience. Headache 2001, 41:500-502.
2. Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet Neurol 2004, 3:475-483.
3. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(Suppl 7):1-96.
4. Headache Classification Subcommittee of the international Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9-160.
5. Headache Classification Committee, Olesen J, Bousser MG, et al.: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742-746.
6. Limmroth V, Katsarava Z, Fritsche G, et al.: Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002, 59:1011-1014.
7. Young WB, Silberstein S: Hemicrania continua and symptomatic medication overuse. Headache 1993, 33:485-487.
8. Evans RW: New daily persistent headache. Curr Pain Headache Rep 2003, 7:303-307.
9. Zeeberg P, Olesen J, Jensen R: Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006, 66:1894-1898.
10. Paemeleire K, Crevits L, Goadsby PJ, Kaube H: Practical management of medication-overuse headache. Acta Neurol Belg 2006, 106:43-51.
11. Torelli P, Manzoni GC: Pain and behaviour in cluster headache. A prospective study and review of the literature. Funct Neurol 2003, 18:205-210.
12. Russell MB: Epidemiology and genetics of cluster headache. Lancet Neurol 2004, 3:279-283.
13. May A, Bahra A, Büchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
14. Katsarava Z, Obermann M, Yoon MS, et al.: Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia 2007, 27:1014-1019.
15. van Vliet JA, Eekers PJ, Haan J, Ferrari MD; Dutch RUSSH Study Group: Features involved in the diagnostic delay of cluster headache. J Neurol Neurosurg Psychiatry 2003, 74:1123-1125.
16. Bahra A, Goadsby PJ: Diagnostic delays and mismanagement in cluster headache. Acta Neurol Scand 2004, 109:175-179.
17. Klapper JA, Klapper A, Voss T: The misdiagnosis of cluster headache: a nonclinic, population-based, Internet survey. Headache 2000, 40:730-735.
18. Kernick D, Matharu MS, Goadsby PJ: Cluster headache in primary care: unmissable, underdiagnosed and undertreated. Br J Gen Pract 2006, 56:486-487.
19. Jensen RM, Lyngberg A, Jensen RH: Burden of cluster headache. Cephalalgia 2007, 27:535-541.
20. Ekbom K, Waldenlind E, Cole J, et al.: Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 1992, 12:254-256.
21. Centonze V, Bassi A, Causarano V, et al.: Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis. Funct Neurol 2000, 15:167-170.
22. Ekbom K, Waldenlind E, Cole J, et al.: Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 1992, 12:254-256.
23. Ekbom K, Krabbe A, Micieli G, et al.: Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalalgia 1995, 15:230-236.
24. Monstad I, Krabbe A, Micieli G, et al.: Preemptive oral treatment with sumatriptan during a cluster period. Headache 1995, 35:607-613.
25. Hering-Hanit R: Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. Headache 2000, 40:41-44.
26. Göbel H, Lindner V, Heinze A, et al.: Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 1998, 51:908-911.
27. Dousset V, Chrysostome V, Ruiz B, et al.: Does repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache? J Headache Pain 2004, 5:110-114.
28. Rossi P, Lorenzo GD, Formisano R, Buzzi MG: Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients. Headache 2004, 44:713-718.
29. Hardebo JE: Subcutaneous sumatriptan in cluster headache: a time study of the effect on pain and autonomic symptoms. Headache 1993, 33:18-21.
30. Evers S, Bauer B, Suhr B: Ergotamine-induced headache associated with cluster headache. Neurology 1996, 46:291.
31. Paemeleire K, Bahra A, Evers S, et al.: Medication-overuse headache in patients with cluster headache. Neurology 2006, 67:109-113.
32. Goadsby PJ: Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006, 2:401.
33. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003, 43:179-190.
34. Wilkinson SM, Becker WJ, Heine JA: Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001, 41:303-309.
35. Evans RW, Bahra A: Migraine and cluster headache: coexistence, laterality, and gender. Headache 2004, 44:186-188.
36. Bahra A, May A, Goadsby PJ: Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002, 58:354-361.
37. Zwart JA, Dyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003, 61:160-164.
38. Srikiatkhachorn A, Tarasub N, Govitrapong P: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000, 40:343-350.
39. Ayzenberg I, Obermann M, Nyhuis P, et al.: Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006, 26:1106-1114.
40. Fumal A, Laureys S, Di Clemente L, et al.: Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006, 129:543-550.
41. Cohen AS, Matharu MS, Burns B, Goadsby PJ: Randomized double-blind, placebo-controlled trial of high-flow inhaled oxygen in acute cluster headache. Cephalalgia 2008, In press.
42. Fogan L: Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol 1985, 42:362-363.
43. May A: Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005, 366:843-855.
44. van Vliet JA, Bahra A, Martin V, et al.: Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003, 60:630-633.
45. Cittadini E, May A, Straube A, et al.: Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006, 63:1537-1542.
46. Rapoport AM, Mathew NT, Silberstein SD, et al.: Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 2007, 69:821-826.
47. May A, Leone M, Afra J, et al.: EFNS Task Force: EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006, 13:1066-1077.
48. Cohen AS, Matharu MS, Goadsby PJ: Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 2007, 69:668-675.